1. Home
  2. ARMP vs CRNT Comparison

ARMP vs CRNT Comparison

Compare ARMP & CRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

N/A

Current Price

$3.34

Market Cap

199.7M

Sector

Health Care

ML Signal

N/A

Logo Ceragon Networks Ltd.

CRNT

Ceragon Networks Ltd.

N/A

Current Price

$2.12

Market Cap

213.6M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ARMP
CRNT
Founded
N/A
1996
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
199.7M
213.6M
IPO Year
1996
2000

Fundamental Metrics

Financial Performance
Metric
ARMP
CRNT
Price
$3.34
$2.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
★ $17.50
$4.83
AVG Volume (30 Days)
257.6K
★ 272.8K
Earning Date
11-11-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$9.08
Revenue Next Year
N/A
$6.40
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.08
$1.85
52 Week High
$14.98
$3.29

Technical Indicators

Market Signals
Indicator
ARMP
CRNT
Relative Strength Index (RSI) 35.95 49.10
Support Level N/A $2.03
Resistance Level $5.63 $2.14
Average True Range (ATR) 0.49 0.06
MACD -0.08 0.00
Stochastic Oscillator 5.26 45.45

Price Performance

Historical Comparison
ARMP
CRNT

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

About CRNT Ceragon Networks Ltd.

Ceragon Networks Ltd is a wireless transport specialist, providing wireless connectivity solutions to markets globally across various industries, including wireless (mobile) network service providers and private networks, enabling them to build new networks and evolve networks towards 4G and 5G services. Its portfolio mainly comprises the IP-20 and IP-50 product series, including integrated multi-technology radio units operating across frequencies from 4 GHz to 86 GHz, as well as single-radio devices used for wireless data transport. Additionally, the company offers turnkey services including: network and radio planning, site survey, installation, network auditing and optimization, and more. Geographically, it derives maximum revenue from India, followed by North America and other regions.

Share on Social Networks: